Our previous studies reported that nicardipine enhanced mitoxantrone-induced cytotoxicity against glioma through competitive inhibition of ABCG2, confirming the sensitizing role of nicardipine with chemotherapeutic agent on gliomas [31]. This evidence concerns the gene ABCG2 and central nervous system cancer.